Part of the DODS Group DODS Group Logo
Menu
Fri, 1 July 2022

Newsletter sign-up

Subscribe now
Search

Follow us:

Articles tagged with: Pharmaceuticals
Brexit has brought with it the opportunity to transform the UK's life-sciences sector Partner content
Coronavirus
By AbbVie
Brexit has brought with it the opportunity to transform the UK's life-sciences sector
If the UK is going to position itself as a global destination for medical innovation, we must embrace and support cutting edge technology and widen access to world-class standards of care.
Let's use this Budget to reform R&D tax credits and kickstart a recovery for British manufacturing Partner content
Coronavirus
By Association of the British Pharmaceutical Industry (ABPI)
Let's use this Budget to reform R&D tax credits and kickstart a recovery for British manufacturing
We need to harness the energy of British science for the task of rebuilding our economy. Bringing capital expenditure into R&D tax credits is a simple, rapidly self-financing way to kick-start growth.
No one is safe, until everyone is safe – there can’t be global vaccine access without breaking Big Pharma monopolies
Coronavirus
By Clive Lewis MP
No one is safe, until everyone is safe – there can’t be global vaccine access without breaking Big Pharma monopolies
Broken promises, limited vaccine roll-out, and now the EU export threat, are stark reminders why we can’t leave the global pandemic response to the whims of the profit-driven pharmaceutical sector.
WATCH: How can we ensure patients access innovative medicines quickly? Partner content
Coronavirus
By AbbVie
WATCH: How can we ensure patients access innovative medicines quickly?
What can the UK Government and others do to ensure the system keeps pace with scientific developments, helping patients overcome delays in accessing innovative new medicines?
Patients must enjoy a higher standard of care – from diagnosis to treatment Partner content
Coronavirus
By Takeda UK & Ireland
Patients must enjoy a higher standard of care – from diagnosis to treatment
Whilst treatment advances and new care models have driven some improvements over the last decade, there is still much more that needs to be done.
How can the UK handle the future threat of pandemics? Partner content
Coronavirus
By Pfizer
How can the UK handle the future threat of pandemics?
Following a virtual parliamentary event hosted by Pfizer UK and the UK Sepsis Trust on ‘Future Infection Threats’, Dr Ron Daniels, Executive Director of the UK Sepsis Trust and Susan Rienow, Head of Pfizer UK’s Hospital Business Unit, explain why there is an urgent need for political action and call for a national strategy on global infection threats.
Increasing vaccination uptake is a priority that must not be overlooked Partner content
Coronavirus
By Pfizer
Increasing vaccination uptake is a priority that must not be overlooked
While a public better protected from disease – regardless of age – is within our reach, we will only make the most of today’s vaccines if we work together to overcome existing barriers and level up access
Focusing on Blood Cancer Post-Covid-19 Partner content
Coronavirus
By Pfizer
Focusing on Blood Cancer Post-Covid-19
We are living in difficult times, and there are many competing challenges for the NHS at present, but we must keep cancer as a priority.
Ministers accused of ‘putting Brexit ideology ahead of lives’ after asking firms to stockpile drugs for no-deal
Brexit
Ministers accused of ‘putting Brexit ideology ahead of lives’ after asking firms to stockpile drugs for no-deal
Ministers are being accused of putting “Brexit ideology ahead of people's lives” after asking drugs firms to begin stockpiling medicines for a potential no-deal Brexit.
US is ‘undermining’ coronavirus response by buying up global supply of Remdesivir drug, minister claims
Coronavirus
US is ‘undermining’ coronavirus response by buying up global supply of Remdesivir drug, minister claims
Business Minister Nadhim Zahawi has suggested the US is “undermining” efforts to fight coronavirus after it bought up the global supply of potential treatment Remdesivir.
Henry VIII powers in the Medicines and Medical Devices Bill must be limited
Health
By Alex Norris MP
Henry VIII powers in the Medicines and Medical Devices Bill must be limited
I have put down an Opposition amendment which will be discussed today, which would limit the powers to two years before requiring Parliamentary approval to extend them.